Search

everythinglearnresearchcommunity

for

Search:↓

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Serum triglyceride levels are not linked to prostate cancer risk.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Baldness may lower the risk of testicular cancer.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Ageratum conyzoides L. extract may effectively and safely treat hair loss.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Epigenetic changes control how adult stem cells work and can lead to diseases like cancer if they go wrong.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

New genes found linked to balding, may help develop future treatments.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

ΔNp63α helps control a protein that stops cancer cells from spreading.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Green tea component EGCG may help prevent hair loss by changing microRNA levels in certain scalp cells.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Targeting specific miRNAs may help treat hair follicle issues caused by hydrogen peroxide.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Conditioned media from mesenchymal stem cells show promise for tissue repair and disease treatment, but more research is needed on their safety and effectiveness.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.